Registration will be from 7:00 AM to 7:50 AM.
7:50-8:00 Welcome/CE Reminders
8:00-9:00: Keynote Presentation: Did We Just Become Best Friends? Microbiology Lab Collaborations with Antimicrobial Stewardship Teams – Erin McCreary, PharmD, BCIDP, FIDSA
-
Learning Objectives:
-
Analyze patient cases or example clinical scenarios to identify specific areas where antimicrobial stewardship teams and microbiology laboratories can partner to improve patient outcomes
-
Outline strategies for effective communication between antimicrobial stewardship teams and microbiology laboratories
-
Discuss potential barriers to antimicrobial stewardship team and microbiology laboratory collaboration and strategies to overcome them
-
9:00-10:00: Panel Discussion: Controversies in Infectious Diseases: Diagnosing, Monitoring, and Treatment – Ryan Dare, MD; Erin McCreary, PharmD, BCIDP, FIDSA; Cole Wood, MD
-
Learning Objectives:
-
Identify infections conventionally treated with intravenous therapy that may be candidates for oral beta-lactams
-
10:00-10:15: Break/Exhibitor Hall
10:15-11:15: No Bed? No Problem: Making Room for OPAT and COpAT – Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP
-
Learning Objectives:
-
Evaluate recent literature supporting the use of OPAT and COpAT
-
Identify one OPAT or COpAT best practice
-
11:15-11:45: Public Health Update from the Arkansas Department of Health – Cassandra Lautredou, MD
-
Learning Objectives:
-
Describe the epidemiological characteristics of various emerging pathogens in Arkansas
-
11:45-1:00: Lunch/Exhibitor Hall
1:00-1:30: Breakout Session #1 (see details below - each presented twice)
1:40-2:10: Breakout Session #2 (see details below - each presented twice)
2:20-2:50: Breakout Session #3 (see details below - each presented twice)
2:50-3:10" Poster Session/Exhibitor Hall
3:10-4:10: Immunization(s) to reduce AMR in 2026 – Robert H. Hopkins, Jr, MD, MACP
-
Learning Objectives:
-
Describe benefits of preventive vaccination on antimicrobial resistance
-
Understand the impact of a strong healthcare professional recommendation on vaccination
-
Implement vaccination strategies to reduce AMP in their clinical setting
-
-
4:10-4:20: Closing Remarks
Breakout Sessions: Each will be presented twice. Schedule TBD
Obsessed with Abscessus (and other Non-Tuberculous Mycobacteria) - Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP
-
Learning Objectives:
-
Identify resources for contemporary NTM treatment options
-
Gray Areas: Unpacking sacral and diabetic foot osteomyelitis - Cole Wood, MD
-
Learning Objectives:
-
Summarize updates on recent literature/guidelines in sacral osteomyelitis and diabetic foot infections
-
Discuss antibiotic regimens for sacral osteomyelitis and diabetic foot infections, including IV/PO switch and appropriate duration
-
-
The Front Door of Resistance: Practical Stewardship Approaches for the ED - Trager D. Hintze, PharmD, BCCCP
-
Learning Objectives:
-
Describe how emergency department workflows uniquely influence stewardship opportunities and challenges
-
Identify practical, evidence-based stewardship interventions that can be integrated into ED practice
-
Ctrl+Alt+De-Escalate: Using Dashboards to Power Smart Antibiotic Stewardship - Brett Bailey, PharmD
-
Learning Objectives:
-
Discuss methods for pulling, transforming, and presenting antimicrobial data to support real-time stewardship interventions
-
Outline best practices for partnering with IT and data engineering teams to ensure accuracy, reproducibility, and workflow-friendly dashboard solutions
-
Breaking the Allergy Barrier: Optimizing Delabeling with Cefazolin Test Doses and Amoxicillin Challenge - Mandy Langston, PharmD
-
Learning Objectives:
-
Implement practical strategies to integrate test-dose–based delabeling into hospital policies and interdisciplinary care pathways
-
New UTI Guidelines: Making Men Less Complicated Since 2025 - Lincoln Neal, PharmD
-
Learning Objectives:
-
Identify patient populations who are no longer considered "complicated"; when treating UTI's
-
Be able to recognize a patient with a UTI as complicated vs uncomplicated
-
Assess first line, empiric options in the treatment of cUTI's
-
Joint Accreditation Statement
In support of improving patient care, University of Arkansas for Medical Sciences and Arkansas Antimicrobial Stewardship Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
AMA Credit Designation Statement
The University of Arkansas for Medical Sciences designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation Statement
The University of Arkansas for Medical Sciences designates this live activity for a maximum of 6.5 ANCC contact hours. Nursing contact hours will be awarded for successful completion of program components based upon documented attendance and completion of evaluation materials.
ACPE Credit Designation Statement
These knowledge-based activities will provide pharmacists up to 6.5 contact hours or 0.65 CEU. CE credit information, based on verification of live attendance and completion of the program evaluation, will be provided to NABP within 60 days after the activity completion.
AAPA Credit Designation Statement
The University of Arkansas for Medical Sciences has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
